Novartis doubles Boston expansion to $600M

Already beefing up operations in Cambridge, Massachusetts, Novartis now plans to double the size of that expansion to $600 million. The new office and lab complex will also get an extra 200 to 300 employees over the next five years, the Boston Globe reports. Report

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.